Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Venous Thrombosis × Rivaroxaban × Clear all

Status

Sponsor Class

OTHER 4 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Venous Thromboembolism 5 Neoplasms 4 Treatment of Venous Thromboembolism in Cancer Patients 3 Venous Thrombosis 1 Pulmonary Embolism 1 Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1 Embolism 1

Interventions

Dalteparin 3 abelacimab 2 MAA868 2 edoxaban 1 calcium heparin 1 bemiparin 1 apixaban 1 Tinzaparin 1 Rivaroxaban 1 Nadroparin 1 Heparin, Low-Molecular-Weight 1 Heparin 1 Fondaparinux 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02742623 2023-11-07

COSIMO

Bayer

Neoplasms, Pulmonary Embolism, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡